Chinese Pharma's Latest Race to the Bottom on Pricing - PharmaBoardroom
China's roll-out of a 25-province expansion to the 4+7 pilot procurement scheme has seen pharma companies scrambling to cut prices for their drugs even further in the latest bidding war. Pharma companies in China are facing yet another intense race to the bottom on pricing. On the 24th of September, the country's 10-month pilot ...